The STING pathway targeting technologies market is projected to grow at an annualized rate of ~25%- Roots Analysis

Posted April 1, 2021 by ellaturner

Roots Analysis has done a detailed study on STING Pathway Targeting Therapeutics and Technologies, 2020-2030.” covering key aspects of the industry and identifying future growth opportunities.

To order this 310+ page report, which features 150+ figures and 200+ tables, please visit this link

Key Market Insights
 Many small / macro molecule-based STING pathway modulators are currently being evaluated as monotherapies as well as in combination with other drugs
 The pipeline features candidates targeting different therapeutic areas and designed for administration through a variety of routes; majority of such therapeutics are being developed as third-line and second-line treatments
 In recent years, several well funded start-ups have entered this field of research, and are gradually developing proprietary products based on the STING pathway for the treatment of a variety of indications
 In addition, a number of big pharmaceutical players have also partnered with developers focused on STING targeting molecules in order to expand their respective capabilities in this upcoming field of pharmacology
 Published scientific literature indicates that both industry and academic players have made equal contributions to the innovation in this field; the major focus of such studies is presently on anti-cancer therapeutics
 Several non-profit organizations have extended financial support to aid research efforts in this domain; the current focus appears to be on drug development and disease modelling studies
 Foreseeing a lucrative future, private and public investors have invested capital worth over USD 2.5 billion, across more than 80 instances, in companies involved in STING pathway research
 The rising interest is also reflected in recent partnership activity, involving the active participation of both international and indigenous companies; majority of the deals have been focused on novel technology platforms
 Multiple companies are developing novel technology platforms for enhancing the research and development of STING pathway targeting therapeutics
 Technology developers are expected to continue relying on licensing agreements involving different STING modulators as their primary source of revenues in the foreseen future

For more information, please visit

Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]

-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Roots Analysis
Business Address California
Country United States
Categories Biotech
Last Updated April 1, 2021